DelveInsight, a leader in pharma consulting services, conducted an Asset Prioritization Analysis for a pharmaceutical client ...
A new treatment at Unity Point Health is offering promising results for those with irregular heartbeats, otherwise known as ...
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...
Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA-approved device to treat persistent ...
Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than standard anticoagulants.
If you geek out on wearable electronics, get ready to feel an excited tingle. Even if you find wearable electronics that ...
Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even ...